Jennifer L. Baker
University of California, San Diego
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jennifer L. Baker.
Plastic and Reconstructive Surgery | 2014
Brian Mailey; Jennifer L. Baker; Ava Hosseini; Zeni Alfonso; Strasser P; Kevin Hicok; Cohen; Amanda A. Gosman; Marek Dobke; Anne M. Wallace
Suday, M arch 9, 2014 effect. The angiogenic effect of PRP itself and PRP-treated ASCs will enhance the vascular supply to maintain the adipocyte survival within fat graft. Furthermore, the stemness effect of PRP increases the renewal and differentiation capabilities of ASCs which can be the cell depot required in fat graft survival. 131 adipose derived Stem cell count is influenced by receipt of chemotherapy in Breast cancer Patients
Annals of Plastic Surgery | 2013
Brian Mailey; Salim Saba; Jennifer L. Baker; Christopher Tokin; Sean Hickey; Ryan Wong; Anne M. Wallace; Steven R. Cohen
IntroductionThe role of regenerative cells in adult human fat is still unfolding. At present, limited clinical studies comparing patient satisfaction with cell-enriched fat transfer (CEFT) to conventional autologous fat transfer (AFT) for aesthetic indications have been performed. Herein, we present our data obtained from patient satisfaction questionnaires. MethodsPatients undergoing fat grafting received AFT or CEFT. Study participants were surveyed for overall satisfaction, symmetry, deformity, scarring, and pigmentation. Hospital charts were reviewed for complications, and patient survey responses between the groups were compared. ResultsBetween January 2009 and September 2011, 36 patients had 6-months follow-up and were mailed surveys. Of these, 17 (12 CEFT and 5 AFT) returned completed Patient Satisfaction Rating surveys. At a median follow-up time of 10.7 months, the overall mean satisfaction rate was 5.2 of 6 (5.3 vs 5.0 for CEFT and AFT, respectively, P = 0.42). There were no significant differences about deformity (5.1 vs 4.7, P = 0.50), symmetry (4.5 vs 5.0, P = 0.48), or scarring (5.3 vs 4.5, P = 0.23). However, pigmentation was improved in the CEFT vs the AFT groups (P < 0.001). No patients in the AFT group noted skin pigmentation improvement, whereas 7 of 12 receiving CEFT noted improvement in skin pigmentation. ConclusionsCell-enriched fat transfer to the face and body of aesthetic patients produces high satisfaction rates. Our preliminary data demonstrates similar satisfaction with regard to symmetry, scarring, and deformity in patients treated with CEFT versus AFT, without any complications. Unexpectedly, a clinical and statistical improvement in pigmentation was seen for patients treated with CEFT over AFT. Further studies need to be done to better understand this phenomenon.
Methods of Molecular Biology | 2014
Brian Mailey; Ava Hosseini; Jennifer L. Baker; Adam P. Young; Zeni Alfonso; Kevin Hicok; Anne M. Wallace; Steven R. Cohen
Adipose tissue sciences have rapidly expanded since the identification of regenerative cells contained within the stromal vascular fraction (SVF) of fat. Isolation of the SVF, containing adipose-derived stem cells (ADSC), can be accomplished efficiently in the operating room or in the laboratory through enzymatic digestion of the adipose tissue and concentration of SVF. Cells can be directly re-injected as a mesotherapeutic agent, recombined with a tissue scaffold (e.g., cell-enriched fat grafts) or expanded in culture for tissue-engineered cell therapeutics. The potential for cell therapy is under current investigation by researchers around the world. This chapter reviews laboratory methods for isolating ADSCs and the ongoing clinical trials evaluating cell therapeutic efficacy across many specialties, including cardiology, neurology, immunology, tissue engineering, sports medicine, and plastic and reconstructive surgery.
Aesthetic Surgery Journal | 2016
Brian Mailey; Jennifer L. Baker; Ava Hosseini; Jessica Collins; Ahmed Suliman; Anne M. Wallace; Steven R. Cohen
BACKGROUND Surgical rejuvenation alters facial volume distribution to achieve more youthful aesthetic contours. These changes are routinely compared subjectively. The introduction of 3-dimensional (3D) stereophotogrammetry provides a novel method for measuring and comparing surgical results. OBJECTIVES We sought to quantify how specific facial areas are changed after rejuvenation surgery using the 3D camera. METHODS Patients undergoing facial rejuvenation were imaged preoperatively and postoperatively with 3D stereophotogrammetry. Images were registered using facial surface landmarks unaltered by surgery. Colorimetric 3D analysis depicting postoperative volume changes was performed utilizing the 3D imaging software and quantitative volume measurements were constructed. RESULTS Nine patients who underwent combined facelift procedures and fat grafting were evaluated. Median time for postoperative imaging was 4.8 months. Positive changes in facial volume occurred in the forehead, temples, and cheeks (median changes, 0.9 mL ± 4.3 SD; 0.8 mL ± 0.47 SD; and 1.4 mL ± 1.6 SD, respectively). Negative changes in volume occurred in the nasolabial folds, marionette basins, and neck/submental regions (median changes, -1.0 mL ± 0.37 SD; -0.4 mL ± 0.9 SD; and -2.0 mL ± 4.3 SD, respectively). CONCLUSIONS The technique of 3D stereophotogrammetry provides a tool for quantifying facial volume distribution after rejuvenation procedures. Areas of consistent volume increase include the forehead, temples, and cheeks; areas of negative volume change occur in the nasolabial folds, marionette basins, and submental/chin regions. This technology may be utilized to better understand the dynamic changes that occur with facial rejuvenation and quantify longevity of various rejuvenation techniques. LEVEL OF EVIDENCE 4 Diagnostic.
International Journal of Surgical Oncology | 2012
Jennifer L. Baker; Farnaz Hasteh; Sarah L. Blair
Background. Negative margins are associated with a reduced risk of ipsilateral breast tumor recurrence (IBTR) in women with early stage breast cancer treated with breast conserving surgery (BCS). Not infrequently, atypical ductal hyperplasia (ADH) is reported as involving the margin of a BCS specimen, and there is no consensus among surgeons or pathologists on how to approach this diagnosis resulting in varied reexcision practices among breast surgeons. The purpose of this paper is to establish a reasonable approach to guide the treatment of ADH involving the margin after BCS for early stage breast cancer. Methods. the published literature was reviewed using the PubMed site from the US National Library of Medicine. Conclusions. ADH at the margin of a BCS specimen performed for early stage breast cancer is a controversial pathological diagnosis subject to large interobserver variability. There is not enough data evaluating this diagnosis to change current practice patterns; however, it is reasonable to consider reexcision for ADH involving a surgical margin, especially if it coexists with low grade DCIS. Further studies with longer followup and closer attention to ADH at the margin are needed to formulate treatment guidelines.
Plastic and Reconstructive Surgery | 2014
Ava Hosseini; Brian Mailey; Jennifer L. Baker; Zeni Alfonso; Paula Strasser; Kevin Hicok; Steven R. Cohen; Amanda A. Gosman; Marek Dobke; Anne M. Wallace
M arch 7 – 9, 2014 levels, wound healing can be improved. These findings hold promise for translational medicine aimed at improving the outcome of wound healing across a broad range of diseases. In patients with chronic wounds, autologous transplantation of macrophages derived from bone marrow aspirate may represent a viable therapeutic strategy. P45 the effect of Fat harvest technique on adipocyte Viability and adipose-derived Stem cell count
The Journal of Nuclear Medicine | 1990
Richard G. McLean; Richard Smart; David Gaston-Parry; Suzanna Barbagallo; Jennifer L. Baker; Norman R. Lyons; Catherine E. Bruck; D. W. King; D. Z. Lubowski; Nicholas A. Talley
Annals of Surgical Oncology | 2015
Jennifer L. Baker; Minya Pu; Christopher Tokin; Carl K. Hoh; David R. Vera; Karen Messer; Anne M. Wallace
Clinical Breast Cancer | 2015
Jennifer L. Baker; Richard Schwab; Anne M. Wallace; Lisa Madlensky
Journal of Surgical Research | 2014
Ava Hosseini; Jennifer L. Baker; Christopher Tokin; Zhengtao Qin; David J. Hall; Dwayne G. Stupak; Tomoko Hayashi; Anne M. Wallace; David R. Vera